APOA1 and coronary artery disorder: HDL-C/apoA-I ≤ 0.89 mmol/g showed significant interactions with FT3 ≤ 4.5 pmol/L on CAD risk in patients with hypertension (OR = 2.446, 95% CI = 1.570–3.813).